story of the week
Larotrectinib Effective in TRK Fusion–Positive Cancers in Adults and Children
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children
N. Engl. J. Med 2018 Feb 22;378(8)731-739, A Drilon, TW Laetsch, S Kummar, SG DuBois, UN Lassen, GD Demetri, M Nathenson, RC Doebele, AF Farago, AS Pappo, B Turpin, A Dowlati, MS Brose, L Mascarenhas, N Federman, J Berlin, WS El-Deiry, C Baik, J Deeken, V Boni, R Nagasubramanian, M Taylor, ER Rudzinski, F Meric-Bernstam, DPS Sohal, PC Ma, LE Raez, JF Hechtman, R Benayed, M Ladanyi, BB Tuch, K Ebata, S Cruickshank, NC Ku, MC Cox, DS Hawkins, DS Hong, DM HymanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.